Pfizer Sales Force “Reset” Recognizes Realities Of ACO World, Exec Says
Executive Summary
Drug company sales forces have an opportunity to play a larger role in assisting ACO organizations to achieve their goals, Pfizer’s John Zgombic pointed out, because focusing only on a transactional sale with the physician “is no longer valid.”
You may also be interested in...
CMS Responds To Pioneer ACO Concerns About Meeting Quality Measures
CMS says it will expect Pioneer ACOs to meet quality performance benchmarks in 2013 based on actual Medicare fee-for-service and Medicare Advantage performance data. The ACOs had requested a delay.
Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care
Thirty-two "Pioneer" accountable care organizations began operations with the new year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.